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Abstract
Background: Cell membrane interactions rely on lipid bilayer constituents and molecules inserted within the membrane,
including specific receptors. HAMLET (human a-lactalbumin made lethal to tumor cells) is a tumoricidal complex of partially
unfolded a-lactalbumin (HLA) and oleic acid that is internalized by tumor cells, suggesting that interactions with the
phospholipid bilayer and/or specific receptors may be essential for the tumoricidal effect. This study examined whether
HAMLET interacts with artificial membranes and alters membrane structure.
Methodology/Principal Findings: We show by surface plasmon resonance that HAMLET binds with high affinity to surface
adherent, unilamellar vesicles of lipids with varying acyl chain composition and net charge. Fluorescence imaging revealed
that HAMLET accumulates in membranes of vesicles and perturbs their structure, resulting in increased membrane fluidity.
Furthermore, HAMLET disrupted membrane integrity at neutral pH and physiological conditions, as shown by fluorophore
leakage experiments. These effects did not occur with either native HLA or a constitutively unfolded Cys-Ala HLA mutant
(rHLAall-Ala). HAMLET also bound to plasma membrane vesicles formed from intact tumor cells, with accumulation in certain
membrane areas, but the complex was not internalized by these vesicles or by the synthetic membrane vesicles.
Conclusions/Significance: The results illustrate the difference in membrane affinity between the fatty acid bound and fatty
acid free forms of partially unfolded HLA and suggest that HAMLET engages membranes by a mechanism requiring both
the protein and the fatty acid. Furthermore, HAMLET binding alters the morphology of the membrane and compromises its
integrity, suggesting that membrane perturbation could be an initial step in inducing cell death.
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Introduction
Lipid bilayers maintain cellular integrity by forming interactive
barriers against the environment. They delineate the extracellular
and intracellular spaces and play a critical role in the regulated
uptake and export of essential components. Molecular interactions
with this barrier in vivo may rely on lipid membrane constituents per
se, or on specialized lipid-rich membrane domains, such as lipid
rafts [1]. In addition, molecular recognition mechanisms often
require specific receptors, which are embedded in lipid mem-
branes, and structural modification of these receptors leads to the
activation of highly regulated signaling pathways.
Membrane interactions are also essential in controlling cell
survival and proliferation, and alterations in membrane compo-
sition and function accompany cancer development [2]. Molecules
with selectivity for tumor cell membranes are important, to better
understand the properties of tumor cells and to design agonists
that attack and kill such cells with better selectivity. HAMLET
(human alpha-lactalbumin made lethal to tumor cells) is a complex
of partially unfolded a-lactalbumin (HLA) and oleic acid with
broad tumoricidal activity. The complex interacts with tumor cell
membranes, becoming rapidly internalized and translocated to the
cell nuclei [3]. It appears that HAMLET triggers cell death by
activating several signaling pathways and by interacting with
cellular organelles, including proteasomes and mitochondria [4,5].
HAMLET is also medically relevant, as demonstrated in clinical
studies of human skin papillomas and bladder cancer [6,7].
The mechanism of HAMLET uptake by tumor cells is unclear,
however. HAMLET uptake has previously been quantified by
radioactive labeling, quantitative confocal imaging and flow
cytometry [4,8]. Attempts have also been made to calculate the
equivalents of membrane receptor sites. Such techniques are not
fully applicable to HAMLET and tumor cells, however, due to
rapid uptake of the complex and loss of membrane integrity as a
result of the cell death process. Artificial membranes may thus be
useful to specifically address how HAMLET interacts with lipid
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bilayers. The protein constituent of HAMLET, HLA, is a
14.2-kDa milk protein known to interact with different lipid
membranes, with partially unfolded states like molten globules
having increased affinity for lipid bilayers [9,10,11,12]. Native,
folded HLA alone is not efficiently internalized by tumor cells and
has no effect on cell viability. Unfolding alone does not increase
HLA uptake by tumor cells [13,14], suggesting that there are
major differences in how HAMLET and the fatty acid free protein
component interact with a cell membrane, even after partial
protein unfolding.
In this study, we examined the interactions of HAMLET with in
vitro generated membranes of known composition, and compared
HAMLET to the native or partially unfolded, fatty acid free
proteins. We also examined the effect of HAMLET on plasma
membrane vesicles (PMVs) obtained from tumor cells [15]. We
show that HAMLET interacts with membranes and disturbs their
integrity under physiological conditions. Binding to intact tumor
cell membranes showed a patchy distribution, indicating that
HAMLET may target molecules in specific membrane regions.
Materials and Methods
Materials
1,2-Dioleoylphosphatidylglycerol (DOPG), porcine brain phos-
phatidylserine (PBPS), soybean lecithin (polar extract) and egg
yolk phosphatidylcholine (EYPC) lipids were from Avanti Polar
Lipids (Alabaster, USA). Chemicals were from Merck (Darm-
stadt, Germany) and Sigma-Aldrich (St. Louis, MO, USA). 8-
Aminonaphtalene-1,3,6-trisulfonic acid, disodium salt (ANTS),
and p-xylene-bis-N-pyrimidinum bromide (DPX) used as a
fluorophore and quencher, respectively, in the leakage assay
were from Sigma-Aldrich. Chromatographic matrices were from
Amersham Biosciences (Uppsala, Sweden) (HIC, DEAE-Sepha-
cell) and DEAE-Trisacryl M from BioSephra (Villeneuf, France).
HAMLET
The HAMLET complex was formed from partially unfolded
HLA and oleic acid, as described [16]. Recombinant HLAall-Ala
was expressed in BL21* Escherichia coli using the T7-polymerase-
based vector pAED4 (kindly donated by Peter S. Kim). Expression
was induced by IPTG (Saveen &Werner AB; Limhamn, Sweden),
rHLAall-Ala was purified according to Kim et al [13] with slight
modifications [14]. For fluorescence imaging, HAMLET, HLA
and rHLAall-Ala, were labeled with AlexaFluor 568 (Molecular
Probes, Carlsbad, CA, USA) according to the manufacture’s
instructions.
Cellular Assays
A549 lung carcinoma (ATCC CCL-185) cells were cultured in
RPMI with NEAA, sodium pyruvate and 5% fetal calf serum
(FCS) and Pheochromocytoma (PC12) cells in RPMI with donor
horse serum (10%) and FCS (5%) in collagen IV coated flasks
(VWR International, USA). To study HAMLET uptake, A549
cells were grown overnight on poly-L-lysine chamber slides (Nunc,
Thermofisher, Roskilde, Denmark) and treated with AlexaFluor
568-labeled HAMLET, native HLA or rHLAall-Ala in medium
without FCS (35 mM, 1 hour at 37uC in 5% CO2). Morphological
changes and labeled protein uptake was recorded by real-time
cellular imaging and confocal microscopy of fixed cells (LSM510
META confocal system, Carl Zeiss, Jena, Germany).
To quantify cell death, cells in RPMI without FCS were seeded
into 24 well plates and incubated with different concentrations of
each agonist at 37uC in 5% CO2. ATP measurements used
ATPlite Luminescence ATP detection assay system (PerkinElmer,
Waltham, MA, USA) and Trypan blue exclusion was recorded by
interference contrast microscopy.
Lipid Vesicles
Large Unilamellar Vesicles (LUVs) were produced from EYPC,
PBPS and DOPG, as described [17,18]. The prerequisite amounts
of chloroform-dissolved lipids (1:1 mixes of DOPG:EYPC and
PBPS:EYPC, and EYPC alone) were transferred to Kimble glass
tubes wrapped in aluminum foil. The chloroform solutions were
dried to lipid films under dry N2-pressure, and residual chloroform
was removed under vacuum. The samples were vortexed with
10 mM citric acid/20 mM Na2HPO4 buffer pH 7.0 and allowed
to hydrate overnight. For liposome preparation, the solutions were
subjected to seven freeze-thaw cycles using liquid N2 and a water
bath at 55uC [19]. Hydrated multilamellar structures were
extruded (LIPEX extruder, Northern Lipids, Burnaby, BC,
Canada), forced through two Millipore filters (pore size 200 nm)
10 times using 12-bar N2 pressures and transferred to clean
Kimble tubes for immediate usage. In the ANTS/DPX leakage
experiments, the lipid film hydrating buffer contained 12.5 mM
ANTS and 45 mM DPX. The free fluorophores and quenchers
were removed by gel-filtration on a Sephadex G-75 exchange
column.
A mix of multilamellar and unilamellar giant unilamellar
vesicles (GUVs) were created from soybean lecithin (Polar extract,
45% phosphatidylcholine and 22% phosphatidylethanolamine;
18% phosphatidylinositol and 7% phosphatidic acid) or EYPC
(72% phosphatidylcholine, 11% phosphatidylethanolamine and
16% other neutral lipids). Lipids were dissolved in chloroform
(3 mg in 200 ml of chloroform), dried and then swelled in PBS,
pH 7.2 (3 ml) overnight at 8uC and dispersed (1 mg lipid per ml)
in an ultrasonic bath for 5 minutes. GUVs were then formed by
the dehydration-rehydration method, which previously has been
used for creating GUVs containing functional membranes with
functional ion channels, used for patch-clamping [20]. The lipid
film was allowed to swell on a glass bottom dish for microscopy
(no. 1 glass thickness) for 5 minutes whereby surface-attached
vesicles were formed.
Surface Plasmon Resonance
The Biacore 3000 biosensor system (Biacore AB, Uppsala,
Sweden) was used at 25uC, as described [21]. L1 sensor chip
surfaces were cleaned with a 2-min injection of isopropanol:
50 mM NaOH (1:1) at a flow rate of 20 ml/min, followed by
30 min washing with running buffer (HBS-N buffer: 10 mM
HEPES, pH 7.4, 150 mM NaCl). LUV solutions were diluted
with running buffer (pH 7.4) or acetate buffer (pH 5.0, 0.6–1 mM)
and injected (flow rate of 10 ml/min), resulting in a deposition
yielding measurements of 4000–6000 RU. The proteins (concen-
tration range of 0–80 mM and dissolved in either buffer at pH 7.4
or pH 5.0, to match the buffer used in the previous step) were
injected over the immobilized LUVs (flow rate of 100 ml/min).
The sensor chip surface was regenerated by injecting isopropa-
nol:50 mM NaOH (40:60, v/v) and running buffer. Non-specific
binding in the reference cell was subtracted. Binding affinity was
estimated by fitting 3-parameter sigmoidal function to all
concentration-RU data pairs, by nonlinear least-squares analysis,
yielding S0.5-values reflecting the protein concentration necessary
for a half-maximal response [21]. The fitting procedure also
provided error estimates of the S0.5-values. The BIAevaluation
program, version 3.2 (Biacore AS) was used for analysis of the
sensorgrams. Curve fits were performed using Sigmaplot version
9.01 (Systat Software, Inc.).
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Fluorescence-Monitored Leakage Assays
LUV integrity was examined according to Ellens et al [22]. LUVs
with ANTS/DPX encapsulation were diluted to 1 mM lipid
concentration using citrate/Na2HPO4 at pH 5.0 or 7.0. Half-
milliliter volumes were added to a 10 mm Hellma GmbH&Co
quartz cuvette, and fluorescence was measured with a Perkin-Elmer
LS5 Luminescence Spectrometer. Volumes of protein and oleic acid
(OA) stock solution were added stepwise directly to the cuvette with
gentle mixing (cumulative protein concentration 1, 5, 10, 20, 40, 60
and 80 mM). Fluorescence was recorded for each concentration
(355 nm excitation, 450–550 nm emission, scan speed of 200 nm/
min, 3 and 5 nm slit widths for the excitation and emission
pathways), 1 min after addition of the protein 25uC. Spectra were
dominated by ANTS fluorescence (lmax at 510 nm). The emission
intensity at this wavelength depends on ANTS/DPX proximity,
and an increased intensity indicates loss of liposome integrity as the
average distance between ANTS and DPX increases. Controls were
measured and subtracted. Triton X-100 was added to the cuvette to
a final concentration of 2 mM and fluorescence at 510 nm was
arbitrarily set to 100%, i.e., complete LUV breakdown. Fluores-
cence at 510 nm prior to addition of stock solution was arbitrarily
set to 0%, i.e., no leakage. This way of benchmarking the resulting
change in fluorescence is convenient for comparing leakage
responses for liposomes of a given lipid mix. The values represent
the means of two experiments (,5% variation was obtained). The
leakage assay is a well-established technique that has been optimized
to make variations in quantum yield negligible [22], as recently
reviewed and validated by Almeida and Pokorny [23]. Controls
were performed to confirm that increases in fluorescence are not
caused by changes in the molecular environment at the end-point of
the experiments (i.e. by the presence of HAMLET,HLA and Triton
X-100 at defined concentrations), and are uniquely associated to the
leakage from liposomes. Briefly, controls consisted of measuring the
effect of HAMLET or HLA addition, in the absence or presence of
Triton X-100, on the fluorescence at 510 nm (355 nm excitation) of
samples of ANTS and ANTS/DPX at different concentrations. The
additions did not cause differences in the fluorescence intensity of
ANTS.
Imaging of HAMLET Interactions with Artificial Lipid
Membranes
Alexa-labeled HAMLET or controls were added to GUVs in
glass bottom dishes (0.5 mg/ml with 10% fluorescently labeled
protein). Unbound protein was removed after 20 minutes using
precision syringe pumping (15 minutes 2 ml/min). Microphoto-
graphs were taken before and after the labeled proteins were
added, using confocal laser scanning microscopy (Leica TCS SP2
RS, Wetzlar, Germany), with a PL APO CS 636/1.2 W corr
objective for image acquisition. Brightness and contrast was
adjusted in the Leica software. For intensity profile measurements,
line scans were obtained with Image J software (http://rsbweb.nih.
gov/ij/). An inverted fluorescence microscope (Leica DMI 6000B)
was used to record morphological changes (bright-field, Leica
DFC350FX camera system).
Plasma Membrane Vesicles
Pheochromocytoma (PC12) cells were cultured for 2–4 days and
plasma membrane vesicle (PMV) formation was induced as
described by Bauer et al [15]. PC12 cells with surface-attached
PMVs and free vesicles were then rinsed twice in washing buffer
and transferred to a glass bottom dish (Wilco well) for incubation
with Alexa-labeled proteins. PMVs from lung carcinoma cells
(A549) were prepared by the same technique.
Results
1. HAMLET Interacts with Neutral and Negatively
Charged Membranes at Physiological pH
To understand the membrane affinity of HAMLET, we
examined its interaction with biologically relevant membranes in
vitro, using surface plasmon resonance with LUVs immobilized on
a BiaCore L1 sensor chip.
The composition of the LUVs chosen was based on previous
studies of HLA interacting with and penetrating into such bilayers.
Briefly, binding was optimal for lipid mixtures with an overall
negative charge of 50% [24] achieved by 1:1 mixtures containing
either DOPG or PBPS as the negative component, and EYPC as
the zwitterionic component. Liposomes prepared with DOPG or
PBPS alone would contribute 100% negative charge, while EYPC-
only liposomes would have 0%; thus, a 1:1 mixture yields 50%
negative charge. As fluidity also defines the membrane quality of
potential importance for HLA-membrane interactions{Agasoster,
2003 #165},three types of LUVs (DOPG:EYPC, PBPS:EYPC
and EYPC lipid mixtures) representing different states of fluidity
and charge were used to investigate HAMLET binding (Fig. 1A).
The DOPG:EYPC liposomes are in the fluid ld-state, while the two
latter species are close to their transition temperature, Tc [24,25].
Since 18:1 oleic acid acts as the HAMLET co-factor, the amount
of 18:1 fatty acid 18:1 acyl chains in the liposomes is of interest
when interpreting the binding results. The DOPG:EYPC lipid mix
contains 66% 18:1 acyl chains, while the PBPS:EYPC and EYPC
mixtures contain approximately 33%.
HAMLET bound strongly and in a concentration-dependent
manner to all three membranes at near physiological conditions
(pH 7.4, 150 mM NaCl), with only small differences in absolute
binding and S0.5 values (S0.5-values ranging from 6.99–7.84, with
standard errors in the range of 0.07–0.40; Figs. 1A and B).
HAMLET binding was not influenced by membrane fluidity,
charge or 18:1 fatty acid acyl chain composition. HLA did not
bind to any of the LUVs under physiological conditions (Fig. 1A),
confirming previous studies where a pH,5 was optimal for HLA
binding to bilayers with 50% negatively charged phospholipids.
The results show that HAMLET binds broadly to membranes
under physiological conditions, in contrast to HLA.
2. HAMLET Interacts with Giant Unilamellar Vesicle
Membranes
The membrane interactions of HAMLET were further
investigated by confocal microscopy imaging of GUVs composed
of EYPC or soybean lipids at pH 7. LUVs were not suitable for
confocal imaging, as they do not form stable unilamellar vesicles
under these conditions. The GUV’s, prepared by dehydration-
rehydration, yielded a mixture of unilamellar (single layer) and
multilamellar (several layers) phospholipid membranes. The
membrane properties of the respective vesicles were the same,
however, regardless of size and structure. Conclusions were based
on pair-wise analysis within each preparation.
Membranes of EYPC lipid vesicles were clearly visualized by
binding of fluorescently labelled HAMLET, whereas HLA and
free Alexa 568 dye associated more weakly to the vesicles, as
shown by the low fluorescence signal (Fig. 2A). To quantify the
membrane association of HAMLET in unilamellar vesicles, we
used intensity profile measurements with ImageJ software and a
median filter radius of 1.0 pixels. There was a clear HAMLET
association with both EYPC and soybean membranes, but only a
weak signal inside the unilamellar vesicle, suggesting no substantial
internalization of the HAMLET complex (Fig. 2B).
HAMLET Interacts with Membrane
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The results show that HAMLET binds more strongly than
native HLA to both neutral and slightly negatively charged
artificial membranes.
3. Membrane Perturbations by HAMLET
To test if membrane integrity was affected by HAMLET, LUVs
were loaded with ANTS fluorophore and DPX quencher, and
leakage into the extravesicular space was quantified by measuring
ANTS fluorescence. Native a-lactalbumin disrupts liposomes at
pH 5, but has no effect at neutral pH or on zwitterionic liposomes at
acidic pHs [24]. HAMLET disrupted negatively charged (DOP-
G:EYPC and PBPS:EYPC) after one minute at neutral pH
(Fig. 3B,C). Fluorophore leakage was higher for DOPG:EYPC,
followed by PBPS:EYPC (Fig. 3B and C), indicating that the degree
to which HAMLET can alter membrane structure is influenced by
the membrane’s lipid composition and physical characteristics.
HAMLET caused a maximal leakage, 100–120% relative to that
induced by the Triton X-100 control, used for benchmarking the
leakage response within each experimental series on a given
liposome lipid mix. Such high relative permeability suggests that
HAMLET is a very effective disruptor of negatively charged
membranes at neutral pH. HAMLET bound zwitterionic vesicles
(EYPC) (Fig. 1A) and although no disruption was observed at
neutral conditions (Fig. 3A), leakage was measured at pH 5.0
(Fig. 3D). Free oleic acid had no detectable effect on LUVs
independent of phospholipidic composition (Fig. 3). Thus, HAM-
LET, but not HLA or oleic acid, permeabilizes negatively charged
lipid bilayers under physiological conditions. Moreover, HAMLET
is a very efficient disruptor of DOPG:EYPC and PBPS:EYPC
vesicles, with the former, enriched in oleoyl-sidechains, being even
more susceptible to disruption by HAMLET than by Triton X-100.
We also documented the effect of HAMLET on membranes by
light microscopy. Vesicles made of EYPC in PBS buffer at pH 7
remained morphologically unchanged for one hour, but the addition
of HAMLET affected the shape of both multi- and unilamellar
vesicles. We observed a change from round and defined to
elongated, heterogeneous morphology after 40 minutes (Fig. 4). In
addition, continuous monitoring revealed an increase in membrane
movement, with a subsequent increase in the number of unilamellar
structures (data not shown). The contribution of protein unfolding to
this change in membrane morphology was examined by comparing
HAMLET to nativeHLA and to the rHLAall-Ala mutant, which lacks
disulphide bonds and is therefore unable to fold into the native state.
Morphological changes of membrane vesicles were not observed
after treatment with either native HLA or rHLAall-Ala.
The results show that HAMLET, but not HLA or rHLAall-Ala,
alters the morphology of membrane vesicles.
4. Interaction of HAMLET with PMVs from Intact Tumor
Cells
To compare the effect of HAMLET on artificial protein-free
membranes versus tumor cell membranes (containing membrane
receptors), we prepared PMVs from the tumor cells PC12 [15].
Free PMVs and PMVs (blebs) still attached to cells were exposed
to Alexa-labeled HAMLET at concentrations corresponding to
the LD50 cell death value (0.5 mg/ml). Alexa-labeled HLA and
free Alexa dye were used as controls.
HAMLET bound strongly to tumor cell PMVs (Fig. 5A, I & II).
In contrast to the artificial protein-free membranes, the HAMLET
distribution on PMVs was patchy, indicating that specific
membrane regions may have higher affinity for the complex.
There was no clear evidence of translocation across the membrane
into the interior of the PMVs, but the remainder of the tumor cells
from which the blebs had been derived fluoresced strongly,
showing that Alexa-labeled HAMLET had been taken up. Alexa-
labeled HLA bound weakly to the PMVs and cell remnants
(Fig. 5A, III). Alexa dye did not interact with the PMVs per se, but
cells fluoresced weakly, possibly due to non-specific uptake
through the ruptured plasma membrane (Fig. 5A, IV).
To confirm our results, we tested in parallel PMVs from another
tumor cell line, A549 lung carcinoma cells, and used a different
visualization marker. The vesicles also bound HAMLET with a
patchy distribution, as visualized with Nile red detection (Fig. 5B
I–III). After 20 minutes, a change in membrane morphology was
observed, with an accumulation of Nile red in the membranes
accompanied by elongated, convoluted shapes.
Figure 1. Interaction of HAMLET with vesicular membranes under physiological conditions. A) HAMLET and HLA interact with LUVs
made of DOPG:EYPC (dark green cirkcle), PBPS:EYPC (light green circle) or EYPC (triangle) on BiaCore L1 sensor chips. Response Units were measured
as a function of HAMLET (solid line) or HLA (dashed line) concentration. Three-parameter Hill-functions where fitted to the HAMLET data series,
yielding S0.5-values, indicated by grey boxes in the figure for the interaction of the protein variant with LUVs made of DOPG:EYPC(S0.5 = 7.8460.40),
PBPS:EYPC (S0.5 = 6.9960.07) or EYPC (S0.5 = 7.2460.21) at pH 7.4. No HLA binding to the LUVs was detected under these conditions. B)
Representative sensorgrams of HAMLET interacting with PBPS:EYPC at increasing concentrations of protein.
doi:10.1371/journal.pone.0009384.g001
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Oleic Acid Binds PMVs but Does Not Disrupt LUVs or
GUVs
In parallel with HAMLET and HLA, the different vesicle
preparations (LUVs, GUVs, and PMVs) were exposed to OA, at a
concentration corresponding to the stoichiometry of 4–6 OA
residues per HLA in the HAMLET complex. In ANTS/DPX-
loaded vesicles, OA alone did not cause an increase in extravesicular
fluorescence, indicating that themembranes remained intact (Fig. 3).
In the membrane morphology studies, OA alone did not cause any
detectable change in vesicle shape or flexibility (data not shown).
OA did incorporate into PMV membranes. However, OA became
associated with the PMVs, resulting in weak fluorescence compared
Figure 2. Confocal imaging of HAMLET binding to lipid membranes in GUVs. A. Differential interference contrast images and corresponding
fluorescence confocal microscopy images. EYPC lipid vesicle membranes were visualized after application of Alexa-labeled HAMLET (I), HLA (II) or free Alexa
568 dye (III). HAMLET bound tomultiple layers of lipid membranes in the multilamellar vesicles. Vesicles after application of Alexa-labeled HLA or free Alexa
568 dye indicated weak fluorescence association. B. Membrane detection of LUVs by fluorescence confocal microscopy, and corresponding intensity profile
measurements, using ImageJ software and a median filter radius of 1.0 pixels to process the images before the profile measurements. I & II) Binding of
HAMLET to EYPC vesicles; confocal micrograph and corresponding DIC microscopy images. White arrowheads illustrate unilamellar structures. III) Intensity
profile measurement across the line shown in I, confirming the strong association of HAMLET to the membrane. IV) Binding of Alexa-labeled HAMLET to
soybean phorphoryl choline vesicles. V) Corresponding DIC micrograph. Black arrowheads illustrate unilamellar structures and the black arrow indicates a
multilamellar structure. VI) Intensity profile measurement of the line shown in IV. HAMLET bound strongly to soybean vesicle membranes.
doi:10.1371/journal.pone.0009384.g002
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to HAMLET, but concentrated in spots on the membrane (arrows
in Fig. 5C I–III) indicating an accumulation in membrane dots.
There was no change in PMVmorphology comparable to that seen
with HAMLET.
HAMLET Internalization and Cell Death Require Both
Unfolded HLA and Oleic Acid
To further examine membrane binding of intact tumor cells,
A549 lung carcinoma cells were exposed to Alexa-labeled
HAMLET or HLA. Membrane interactions and effects on tumor
cell morphology were first recorded by live-cell imaging (Fig. 6A).
HAMLET rapidly became associated with the cell membrane, and
internalization occurred immediately (Fig. 6A).
Over a six-hour period, HAMLET-treated cells changed
morphologically. HAMLET became membrane-associated and
internalized after 30 minutes, and after three hours the cells
rounded up and formed blebs. After six hours, membrane integrity
was lost and all cells had internalized HAMLET (Fig. 6A). There
was no binding, uptake or morphological change after cell
exposure to the protein component of HAMLET alone. Neither
fatty acid free HLA nor the unfolded mutant, rHLAall-Ala, entered
or killed cells (Fig. 6B). In HAMLET-treated cells, tumor cell
death coincided with HAMLET internalization, and was detected
by trypan blue exclusion and ATP measurements after one- and
three-hour exposures, (Fig. 6C).
The results show that membrane binding and internalization by
tumor cells require partially unfolded HLA and oleic acid.
Importantly, unfolding alone did not enable HLA to bind to cell
membranes, become internalized or kill carcinoma cells.
Discussion
The tumoricidal HAMLET complex interacts with the tumor cell
membrane, is internalized and translocates to the cell nucleus [3].
This study used artificial membranes to define whether HAMLET
can interact with phospholipid bilayers in the absence of specific
tumor cell membrane constituents. We showed that HAMLET
bound membranes at physiological pH, and as a result, perturbed
the membrane integrity and caused leakage of vesicular contents to
the exterior. In addition, the morphology of vesicles composed of
natural lipid mixtures was altered. The effects were quite dramatic,
differing markedly from those of natively folded HLA, which failed
to bind membranes at neutral pH. Significant HLA binding has
only been recorded at pH,5, where the proton gradient near the
negatively charged membrane is thought to be sufficient to remove
negative charges at key residues, and thus drive protein unfolding
necessary for membrane binding [11,26,27]. To determine whether
Figure 3. Leakage of ANTS/DPX from LUVs in response to HAMLET, monitored by fluorescence. ANTS/DPX fluorophore leakage across
liposome membranes after one-minute exposure to HAMLET (red circle), HLA (black circle), water (yellow triangle) or oleic acid (green triangle). A) EYPC
LUVs at pH 7.0. B) DOPG:EYPC liposomes at pH 7.0. C) PBPS:EYPC at pH 7.0. D) EYPC LUVs at pH 5.0. The fluorescence (at 510 nm) of undisturbed LUVs
was set to 0% and that of vesicles disrupted by Triton X-100 was set to 100%. The leakage response is presented as a function of polypeptide/oleic acid
concentration in the fluorescence cuvette, except for water, which was added to reach the intended concentration of polypeptide/oleic acid.
doi:10.1371/journal.pone.0009384.g003
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protein unfolding is sufficient to create a membrane-interactive
form of HLA, we used the mutant rHLAall-Ala, which lacks all four
disulfide bonds and therefore cannot adopt the native HLA fold
[14]. This mutant did not bind to membranes to the same extent as
HAMLET or perturb membrane function at conditions amenable
for HAMLET binding. The results suggest that protein unfolding
and the fatty acid together increase membrane affinity and that the
oleic acid bound form engages membranes by a mechanism
requiring both the protein and the fatty acid.
The artificial, protein-free vesicles in this study contained
phospholipid extracts from natural sources (egg yolk, porcine brain
and soybean) and one synthetic lipid (DOPG) carrying two oleic
acids. The extracts were used to ensure that the fluidity and charge
of the membranes reflected naturally occurring compositions [28].
The synthetic lipid was added to test the effect of oleic acid moieties
on the membrane. HAMLET bound to the artificial membranes
regardless of lipid composition, charge or oleic acyl chain content.
In contrast to HLA and derivatives, HAMLET even bound to
membranes made only of EYPC, which has an overall neutral
charge under these experimental conditions, indicating that the
interaction is not dominated by long-range columbic interactions.
For native HLA, at least, membrane curvature is of secondary
importance for binding relative to membrane charge and the
protein’s membrane-bound folding state [24,28,29]. That HAM-
LET has high affinity for a range of liposomes examined here
(neutral, charged, LUVs and GUVs) suggests that curvature is also
less important for the partially folded protein. A previous study [25]
of SUVs prepared with similar lipid mixtures suggested that at room
temperature the mixtures are either in the ld-state (DOPG:EYPC)
or within the transition temperature interval (EYPC, PBPS:EYPC).
Moreover, HLA increases the membrane Tc upon binding.
Whether this latter feature is true of HAMLET is an open question,
but we interpreted this as indicating that the degree to which the
native protein penetrates the membrane and the physical state of the
membrane were coupled.
Thermodynamic access to intermediately folded protein states has
been proposed to drive membrane binding of proteins, including
HLA [27,30,31,32]. Membrane curvature is a known contributor in
many systems. However, for HLA interacting with negatively
charged membranes, this factor is less important than bulk
conditions and membrane charge [24,28]. For HAMLET, unfolding
of HLA alone was not sufficient to create membrane affinity and to
permeabilize the membrane, emphasizing that the role of oleic acid,
in addition to kinetically trapping HAMLET in its active
conformation, might be to enhance membrane affinity. Increased
hydrophobicity through the fatty acid acyl-chain, or modulation of
the local charges on the protein through shielding and hydrogen
bonding are possibilities. It remains unclear if short-range forces
could consolidate the interaction with the subset of conformations
available that are most favorable for binding the membrane.
Free fatty acids are used by all cells as an energy source and as
building blocks for hormones, glycolipids and lipoproteins and are
constantly taken up by cells. Although the uptake mechanisms are
not fully understood, a range of receptors and transport systems
are thought to be involved [33]. Fatty acids also cross lipid bilayers
by receptor-independent mechanisms; this has been ascribed to
their hydrophobicity [34]. We have confirmed elsewhere that
tumor cells internalize free oleic acid as well as the HAMLET
complex, suggesting that the primary membrane interactions may
depend on oleic acid as well as the protein (manuscript in
preparation). In the present study, neither HLA nor oleic acid
alone could alter membrane structure or disrupt vesicles,
suggesting that both the unfolded protein and the lipid are
necessary bind to and disrupt membranes.
The difference in membrane affinity between HAMLET and
HLA was confirmed using tumor cell PMVs, suggesting that the
artificial membrane systems might reflect important properties of
intact cell membranes. Previous studies using microscopy and
proteomic analysis of cytosolic proteins have shown that the PMV
interior is filled with cytosolic molecules but does not contain
cytoskeletal elements such as actin or microtubules [35]. The lipid
composition of the PMVs is representative of the donor cell plasma
membrane, with phospholipid/cholesterol ratios of 2:1 [36] and
PMVs display phase separation of proteins and lipids [37].
HAMLET was distributed in patches on PMV membranes,
indicating that specific membrane regions bound HAMLET more
strongly than others. Thus, whereas lipid bilayers and their
constituents are sufficient for HAMLET binding, specific receptors
for HAMLET or oleic acid could also contribute in tumor cell
interaction. This is consistent with preliminary studies indicating
that HAMLET internalization is influenced by specific signaling
pathways and by the metabolic state of tumor cells (P. Storm et al
manuscript in preparation). The membrane interactions described
here may allow the complex to reach specific membrane-
associated receptor structures, thus enabling HAMLET to activate
the complex signaling pathways involved in cell death.
Figure 4. HAMLET alters the morphology of lipid vesicles. Bright-
field micrographs showing glass-adherent egg yolk vesicles before and
after a 40-minute exposure to HAMLET, HLA or rHLAall-Ala. At T= 0, the
vesicles were rigid, with predominantly rounded morphology. Following
HAMLET exposure, unilamellar structures were more prominent, the
membranes were elongated and an increase in thermal mobility and
fluidity of the membranes was observed (see arrows, upper panels). The
morphology of vesicles treated with HLA or rHLAall-Ala was unchanged
(see arrows, lower panels).
doi:10.1371/journal.pone.0009384.g004
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Figure 5. Interaction of HAMLET with tumor cell PMVs. Pheochromocytoma cell (PC12) PMVs on glass-bottom dishes were exposed to Alexa-
labeled HAMLET, Alexa-labeled HLA or free Alexa 568 dye. Membrane fluorescence was observed by confocal fluorescence microscopy and
morphology by differential interference contrast microscopy. A) Detection of Alexa-HAMLET on PMVs (I, white arrowheads). Cell remnants are also
highly stained (I, right panel). Black arrowheads indicate the PMV membrane (II). Weak detection of PMVs and cell remnants after application of Alexa-
labeled HLA (III). Free Alexa dye served as a negative control (IV). B) PMVs from A549 cells exposed to HAMLET (35 mM, 0, 10, 20 min) and visualized
with Nile red. An increase in fluorescence intensity and change of shape was observed over time. Internal convoluted membrane structures
developed (arrows). C) PMVs from A549 cells exposed to OA and visualized with Nile red (0, 10, 20 min) showed a gradual increase in membrane
binding at distinct membrane spots (arrows).
doi:10.1371/journal.pone.0009384.g005
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